Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03829462 |
| Title | Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients (NEXT-REGIRI) |
| Acronym | NEXT-REGIRI |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Institut du Cancer de Montpellier - Val d'Aurelle |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA |